Back to FDA Applications sponsored by VALEANT PHARMS NORTH

FDA Drug Application 021894 by VALEANT PHARMS NORTH

Application Number021894
Application Type New Drug Application
Most Recent Label Available Flag
Current Patent Flag
Action Type Approval
Chemical Type New molecular entity (NME)
Therapeutic Potential Priority
Orphan CodeV

Action TypeDuplicate CounterAction DateDocument TypeApplication Document IDSequence NumberDocument TitleDocument URLDocument Date
AP08/15/2008N20654000 8/21/2008
AP08/15/2008N20682000 8/26/2008
AP08/15/2008N20989000 10/9/2008
AP08/15/2008N20990000 10/9/2008
AP08/15/2008N24188000 12/3/2009
AP012/1/2009SLR24648001 1/27/2010
AP012/1/2009SLR24649002 1/27/2010
AP07/6/2011SLR29448004 7/7/2011
AP07/6/2011SLR29450004 7/7/2011
AP05/4/2011SLR28714005 5/5/2011
AP05/4/2011SLR28715005 5/5/2011
AP05/4/2011SLR28725005 5/6/2011
AP08/17/2012SLR33553007 8/27/2012
AP08/2/2013SLR36691009 8/5/2013
AP06/3/2015SLR42981010 6/4/2015
AP06/3/2015SLR42988010 6/4/2015
AP08/25/2015S43734012 8/27/2015

Back to FDA Applications sponsored by VALEANT PHARMS NORTH

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer

Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.